Experience
Biogen Int’l GmbH
Amneal Pharmaceuticals LLC
Represented Biogen in an ANDA litigation against 27 generic drug manufacturers in multiple jurisdictions concerning Biogen’s Tecfidera® (dimethyl fumarate) product for the treatment of relapsing forms of multiple sclerosis.
Biogen Int’l GmbH v. Amneal Pharmaceuticals LLC, 1:17-cv-00823, D. Del., Judges Stark, Noreika
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
Novartis Pharmaceuticals Corporation et al.
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.
Biogen International GmbH
Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.
Grünenthal GmbH et al.
Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.
Biogen MA Inc. et al.
AstraZeneca LP v. SigmaPharm Laboratories
AstraZeneca LP
BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al.
BioDelivery Sciences International, Inc. et al.
Grünenthal GmbH et al. v. Actavis Elizabeth LLC et al.
Grünenthal GmbH
Salient Systems Corporation v. Hawk Technology Systems LLC et al.
Salient Systems Corporation
Pioneer Hi-Bred International, Inc. et al. v. Syngenta Seeds, LLC
Pioneer Hi-Bred International, Inc. et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.